Why AI, Cloud & Sustainability Strategies May Collide
By Martyn Williams
February 16, 2026
UK pharma’s digital ambition is starting to work against it, writes Martyn Williams of COPA-DATA UK
3 min read
False
By Martyn Williams
February 16, 2026
UK pharma’s digital ambition is starting to work against it, writes Martyn Williams of COPA-DATA UK
3 min read
February 13, 2026
Twin-screw extrusion’s role in enabling precise, scalable pharmaceutical manufacturing
7 min read
February 13, 2026
Bead-free microbubble approach aims to simplify cell selection and activation for scalable cell therapy manufacturing
2 min read
February 12, 2026
Why immersive training could be critical to closing the UK’s medicines manufacturing skills gap
4 min read
February 12, 2026
Focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology
1 min read
February 11, 2026
As drug discovery unlocks harder, more powerful molecules, solubility has become the bottleneck. The first of a three-part series discusses the roots of the problem
5 min read
February 10, 2026
New survey finds outdated lab software is driving experiment duplication, workflow bottlenecks, and risky shadow AI use
2 min read
By Christy Eatmon
February 9, 2026
Bringing speed, consistency, and insight to sterile drug inspection
3 min read
By Dan Williams
February 6, 2026
AI, data-sharing, and gene technologies are peering into the future of rare disease drug development, and overcoming economic, regulatory, and diagnostic challenges for transformative therapies.
9 min read
By Chris Moore
February 5, 2026
Why people, process, and purpose matter most
5 min read
False
False
False